BioCentury
ARTICLE | Company News

MediVas, Merck deal

April 9, 2007 7:00 AM UTC

MediVas will receive an undisclosed milestone payment from MRK under a deal in which the companies are applying MediVas' polyesteramide (PEA) copolymer delivery technology to undisclosed oral biologic...